Nov 25, 2024
September 2024: Loma selected for the Women TechEU Program. We are honored to announce that Loma has been selected as a recipient of the Women TechEU grant, a prestigious program by the European Commission that supports female-led deep-tech startups in Europe. This...
Mar 11, 2024
Human ex vivo validation of the potential of Loma’s HPV-targeted immunotherapy has been published in Cancers. The study conducted in collaboration between Loma Therapeutics and Hervolution supports that Loma’s unique immunotherapy can induce strong and functional CD8+...
